Haloperidol acts by reversibly blocking dopamine D2 receptors and the striatal blockade results in catalepsy that is considered a crude model of PD.31 Regardless, since haloperidol is widely shown to have analgesic properties,52 it can be completely ruled out as a potential model to study pain in PD. This evidence concerns the gene DRD2 and Parkinson disease.